Accelerating development of genetic therapies for muscular dystrophies
The aim of MAGIC is to accelerate the development of gene therapies and genome editing strategies for muscular dystrophies by creating advanced humanized muscle models and innovative gene therapy approaches, ultimately improving the lives of individuals affected by these debilitating diseases.
Key Objectives
- Creating accurate humanized muscle models.
- Developing precise gene therapies and genome editing strategies.
- Engineering disease-specific muscle-on-chip devices.
- Assessing safety and efficacy of novel gene therapies.
- Exploring gene editing strategies for neuromuscular disorders.
- Facilitating translation and exploitation of project outputs.
- Ensuring patient perspectives remain central to the research.
See how MAGIC is working to reach these key objectives
Latest News
MAGIC GA Meeting 2024 Rome
On the 20th-22nd of October, 2024 an insightful General Assembly meeting took place in Rome, Italy, kindly hosted by Parent Project aps. The meeting focused on next-generation models and genetic...
Meet the Gene Editing Team- Genethon Institute in the MAGIC Project Consortium
We ask MAGIC partners why they are joining this project. This time, we are speaking with Paola Galbiati, PhD student at the Gene Editing Team, Genethon Institute
MAGIC partner listed in World’s Top 2% Scientists Rankings
Maynooth University has secured its place among global research leaders, with 23 of its researchers recognized in the prestigious World’s Top 2% Scientist Rankings. Compiled by Stanford University...